Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study

Hypertension among people living with HIV receiving dolutegravir-based antiretroviral therapy in ethiopia: a cross-sectional study

Abstract Recently, dolutegravir (DTG) has been associated with weight gain, dyslipidemia, and hyperglycemia, which in turn raise(s) the risk of hypertension. However, little is known about the burden of hypertension among people living with HIV (PLHIV) taking DTG-based therapy in Ethiopia. This stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammed Jemal, Desalegn Abebaw, Yabibal Tsegaye Workineh, Worku Abie Liyew, Tabarak Malik, Adane Adugna
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Hypertension
HIV
People living with HIV (PLHIV)
Dolutegravir (DTG)
ART
Online Access:https://doi.org/10.1038/s41598-025-06145-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1038/s41598-025-06145-z

Similar Items